Prudential plc’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.2M Sell
159,677
-9,400
-6% -$1.24M 0.11% 115
2026
Q1
$23.6M Sell
169,077
-4,299
-2% -$602K 0.14% 84
2025
Q4
$21.3M Sell
173,376
-9,442
-5% -$1.15M 0.17% 87
2025
Q3
$20.3M Sell
182,818
-11,677
-6% -$1.33M 0.15% 92
2025
Q2
$21.6M Sell
194,495
-27,809
-13% -$2.96M 0.13% 80
2025
Q1
$24.9M Sell
222,304
-35,359
-14% -$3.65M 0.12% 62
2024
Q4
$23.8M Sell
257,663
-23,341
-8% -$2.1M 0.12% 64
2024
Q3
$23.6M Sell
281,004
-38,158
-12% -$2.91M 0.12% 70
2024
Q2
$21.9M Sell
319,162
-32,218
-9% -$2.15M 0.15% 70
2024
Q1
$25.7M Buy
351,380
+151,697
+76% +$11.7M 0.2% 54
2023
Q4
$16.2M Sell
199,683
-19,844
-9% -$1.54M 0.16% 73
2023
Q3
$16.5M Buy
219,527
+14,657
+7% +$1.13M 0.18% 65
2023
Q2
$15.8M Sell
204,870
-7,754
-4% -$618K 0.18% 73
2023
Q1
$17.6M Sell
212,624
-13,385
-6% -$1.11M 0.21% 63
2022
Q4
$19.4M Buy
226,009
+43,068
+24% +$3.41M 0.24% 58
2022
Q3
$11.3M Sell
182,941
-356
-0.2% -$22.4K 0.18% 74
2022
Q2
$11.3M Sell
183,297
-14,025
-7% -$868K 0.21% 77
2022
Q1
$11.7M Buy
197,322
+141,640
+254% +$9.05M 0.17% 69
2021
Q4
$4.04M Buy
55,682
+29,534
+113% +$2.03M 0.06% 154
2021
Q3
$1.83M Sell
26,148
-106,353
-80% -$7.47M 0.03% 246
2021
Q2
$9.12M Sell
132,501
-132,187
-50% -$8.83M 0.08% 147
2021
Q1
$17.1M Buy
+264,688
New +$17.1M 0.12% 137
2020
Q3
Sell
-1,863,101
Closed -$143M 621
2020
Q2
$143M Buy
1,863,101
+430,760
+30% +$33M 0.69% 24
2020
Q1
$107M Buy
1,432,341
+1,423,870
+16,809% +$98.4M 0.57% 43
2019
Q4
$550K Sell
8,471
-2,689,085
-100% -$175M ﹤0.01% 418
2019
Q3
$171M Sell
2,697,556
-128,775
-5% -$8.42M 0.5% 53
2019
Q2
$191M Sell
2,826,331
-296,067
-9% -$19.5M 0.58% 45
2019
Q1
$203M Buy
3,122,398
+32,583
+1% +$2.17M 0.73% 30
2018
Q4
$193M Sell
3,089,815
-199,735
-6% -$14M 0.78% 32
2018
Q3
$254M Sell
3,289,550
-558,140
-15% -$42.2M 0.82% 26
2018
Q2
$273M Buy
3,847,690
+339,324
+10% +$24M 0.85% 24
2018
Q1
$264M Buy
3,508,366
+103,039
+3% +$8.19M 0.83% 24
2017
Q4
$244M Buy
3,405,327
+247,331
+8% +$18.8M 0.74% 25
2017
Q3
$256M Sell
3,157,996
-367,171
-10% -$28.1M 0.81% 22
2017
Q2
$250M Buy
3,525,167
+168,200
+5% +$11.2M 0.82% 22
2017
Q1
$228M Buy
3,356,967
+376,394
+13% +$26.5M 0.76% 26
2016
Q4
$213M Buy
2,980,573
+684,104
+30% +$50.8M 0.75% 31
2016
Q3
$182M Buy
2,296,469
+109,469
+5% +$8.89M 0.69% 34
2016
Q2
$182M Buy
2,187,000
+219,741
+11% +$19.5M 0.72% 29
2016
Q1
$181M Sell
1,967,259
-752
-0% -$67.8K 0.73% 31
2015
Q4
$199M Buy
1,968,011
+64,800
+3% +$6.74M 0.81% 24
2015
Q3
$187M Buy
1,903,211
+176,300
+10% +$19.6M 0.8% 31
2015
Q2
$202M Buy
1,726,911
+340,900
+25% +$37.2M 0.77% 29
2015
Q1
$136M Sell
1,386,011
-20,850
-1% -$2.12M 0.6% 40
2014
Q4
$133M Buy
1,406,861
+120,218
+9% +$12.4M 0.56% 42
2014
Q3
$137M Sell
1,286,643
-100,650
-7% -$9.86M 0.57% 44
2014
Q2
$115M Buy
1,387,293
+827,500
+148% +$64.4M 0.48% 57
2014
Q1
$39.7M Sell
559,793
-13,600
-2% -$1.07M 0.18% 138
2013
Q4
$43.1M Buy
573,393
+22,366
+4% +$1.56M 0.18% 141
2013
Q3
$34.6M Buy
551,027
+275,700
+100% +$16.5M 0.18% 140
2013
Q2
$14.1M Buy
+275,327
New +$14.4M 0.08% 178

Other funds holding GILD

Prudential plc's GILD Position: Q2 2026 in Review

Prudential plc reduced its Gilead Sciences (GILD) stake by 5.6% in Q2 2026, selling an estimated $1.24M and leaving 159,677 shares worth $20.2M. The position accounts for 0.11% of the portfolio, ranked #115.

Prudential plc first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $273M in Q2 2018. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Prudential plc held 159,677 shares of Gilead Sciences worth $20.2M as of Q2 2026.
  • Prudential plc sold 9,400 Gilead Sciences shares in Q2 2026, an estimated $1.24M.
  • Gilead Sciences made up 0.11% of Prudential plc's portfolio in Q2 2026, its #115 holding.
  • Prudential plc first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
  • Prudential plc's Gilead Sciences position peaked at $273M in Q2 2018.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Prudential plc's 13F filing for Q2 2026, filed 14 Aug 2026.